US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

NEUROONE MEDICAL TECH

0.5740

+0.00911.61%

Post-market: 0.5700-0.0040-0.70%19:39 EDT

Volume:72.51K

Turnover:41.29K

Market Cap:28.60M

PE:-2.27

High:0.5800

Open:0.5800

Low:0.5600

Close:0.5649

Loading ...

Overview Company News Filings

NeuroOne Medical Technologies Regains Nasdaq Compliance

MT Newswires Live

NeuroOne Medical regains compliance with Nasdaq listing requirements

Neuroone® Regains Compliance With Nasdaq Listing Requirements

THOMSON REUTERS

NeuroOne Reports Record Revenue Boost in Q1 2025

NeuroOne Expects Higher Fiscal Q1 Revenue -- Shares Up

MT Newswires Live

NeuroOne Expects $6.2M Q1 Fiscal 2025 Revenue, Including $3M One-Time Payment From Zimmer Biomet; Product Revenue Jumps 227% To $3.2M; FY25 Product Revenue Guidance Of $8M-$10M With 47%-51% Gross Margin

Neuroone Medical Technologies Corp: for Full Year of Fiscal 2025, Co Is Reiterating Guidance Specific to Product Revenues

THOMSON REUTERS

Neuroone® Announces Preliminary Unaudited First Quarter Fiscal 2025 Revenue Increase to a Record $6.2 Million

THOMSON REUTERS

NeuroOne® Announces Preliminary Unaudited First Quarter Fiscal 2025 Revenue Increase to a Record $6.2 Million

Apogee Enterprises Reports Fiscal 2025 Third Quarter Results

NeuroOne Medical announces change to virtual investor webinar

NeuroOne® Announces Change of Virtual Investor Webinar to Friday, January 10, 2024

NeuroOne® Announces Virtual Investor Webinar on January 9, 2025 at 11:00 a.m. EST

NeuroOne Medical Technologies Corp (NMTC) Q4 2024 Earnings Call Highlights: Strategic ...

NeuroOne FY24 Product Revenue Of $3.45M Vs. $1.95M YoY, GAAP EPS Loss Of $0.46 Compared To $0.65 YoY

Neuroone® Product Revenue Increases 77% to $3.5 Million in Fiscal 2024: Expects Product Revenue to Increase at Least 132% to at Least $8 Million in Fiscal 2025

THOMSON REUTERS

Neuroone Medical Technologies Q4 Net Income USD -3.3 Million

THOMSON REUTERS

Neuroone Medical Technologies Q4 Operating Expenses USD 3 Million

THOMSON REUTERS

NeuroOne® Product Revenue Increases 77% to $3.5 Million in Fiscal 2024: Expects Product Revenue to Increase at Least 132% to at Least $8 Million in Fiscal 2025

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/NMTC/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NMTC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NMTC\",,,,,undefined,":{"symbol":"NMTC","market":"US","secType":"STK","nameCN":"NEUROONE MEDICAL TECH","latestPrice":0.574,"timestamp":1749758400000,"preClose":0.5649,"halted":0,"volume":72505,"hourTrading":{"tag":"盘后","latestPrice":0.57,"preClose":0.574,"latestTime":"19:39 EDT","volume":2026,"amount":1155.079,"timestamp":1749771554870},"delay":0,"floatShares":46155700,"shares":49817835,"eps":-0.252446,"marketStatus":"Not Yet Opened","change":0.0091,"latestTime":"06-12 16:00:00 EDT","open":0.58,"high":0.58,"low":0.56,"amount":41290.814446000004,"amplitude":0.035404,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.252446,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1749801600000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":0.5649,"preHourTrading":{"tag":"盘前","latestPrice":0.5729,"preClose":0.5649,"latestTime":"08:06 EDT","volume":12,"amount":6.8748,"timestamp":1749730018339},"postHourTrading":{"tag":"盘后","latestPrice":0.57,"preClose":0.574,"latestTime":"19:39 EDT","volume":2026,"amount":1155.079,"timestamp":1749771554870},"volumeRatio":0.614387,"impliedVol":1.4254,"impliedVolPercentile":0.384},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NMTC\",,,,,undefined,":{"symbol":"NMTC","floatShares":46155700,"roa":"-83.48%","roe":"-265.18%","lyrEps":-0.460276,"volumeRatio":0.614387,"shares":49817835,"dividePrice":0,"high":0.58,"amplitude":0.035404,"preClose":0.5649,"low":0.56,"week52Low":0.3954,"pbRate":"25.40","psRate":"4.97","week52High":1.39,"institutionHeld":0,"latestPrice":0.574,"eps":-0.252446,"divideRate":0,"volume":72505,"delay":0,"ttmEps":-0.252446,"open":0.58,"prevYearClose":0.8259,"prevWeekClose":0.5817,"prevMonthClose":0.6111,"prevQuarterClose":0.8502,"fiveDayClose":0.589,"twentyDayClose":0.66,"sixtyDayClose":1.01},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NMTC\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2509461544","title":"NeuroOne Medical Technologies Regains Nasdaq Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2509461544","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509461544?lang=en_us&edition=fundamental","pubTime":"2025-02-05 00:51","pubTimestamp":1738687917,"startTime":"0","endTime":"0","summary":"NeuroOne Medical Technologies  said Tuesday it has regained compliance with Nasdaq's minimum share price requirement for continued listing.The company said it was notified by Nasdaq Monday that its bid price deficiency had been cured and NeuroOne was in compliance will all applicable listing standards.Shares of the company were down 2.2% in recent trading.Price: 1.06, Change: -0.02, Percent Change: -2.22","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":[".IXIC","IE00B3QW5Z07.USD","BK4112","LU2095319765.USD","LU2210149790.SGD","NDAQ","IE00BGHQF748.EUR","LU2210150020.SGD","BK4585","IE00BKPKM429.USD","NQmain","NMTC","BK4588","IE00B64PRP62.GBP","BK4082"],"gpt_icon":0},{"id":"2509466354","title":"NeuroOne Medical regains compliance with Nasdaq listing requirements","url":"https://stock-news.laohu8.com/highlight/detail?id=2509466354","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509466354?lang=en_us&edition=fundamental","pubTime":"2025-02-05 00:00","pubTimestamp":1738684807,"startTime":"0","endTime":"0","summary":"NeuroOne Medical (NMTC) Technologies announced that it has regained compliance with the Nasdaq Capital Market’s continued listing standard for the ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neuroone-medical-regains-compliance-with-nasdaq-listing-requirements?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neuroone-medical-regains-compliance-with-nasdaq-listing-requirements?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2210149790.SGD","USAW.SI","NMTC","LU2210150020.SGD","NDAQ","BK4585","NVIW.SI","NQmain","IE00BKPKM429.USD","LU2095319765.USD","MNQmain","USJW.SI","BK4112","IE00BGHQF748.EUR","PSQ","QLD","BK4082","BK4588","QID","IE00B3QW5Z07.USD","TQQQ","SQQQ","TSYW.SI",".IXIC","IE00B64PRP62.GBP"],"gpt_icon":0},{"id":"2508168465","title":"Neuroone® Regains Compliance With Nasdaq Listing Requirements","url":"https://stock-news.laohu8.com/highlight/detail?id=2508168465","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508168465?lang=en_us&edition=fundamental","pubTime":"2025-02-04 23:56","pubTimestamp":1738684560,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250204:nTUA4F8CGT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NMTC","BK4082"],"gpt_icon":0},{"id":"2502801342","title":"NeuroOne Reports Record Revenue Boost in Q1 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2502801342","media":"TipRanks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502801342?lang=en_us&edition=fundamental","pubTime":"2025-01-11 22:30","pubTimestamp":1736605836,"startTime":"0","endTime":"0","summary":"Discover outperforming stocks and invest smarter with Top Smart Score Stocks. Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener. NeuroOne announced a preliminary unaudited revenue increase for the first quarter of fiscal 2025 to a record $6.2 million, significantly up from $1 million in the previous year. The revenue boost includes a $3 million upfront payment from an expanded distribution agreement with Zimmer Biomet for the OneRF Ablation System, along with a 227% increase in product revenue to $3.2 million, which reflects the company’s strengthened market position and strategic partnerships.NeuroOne Medical Technologies Corporation is a medical technology company that specializes in developing and commercializing minimally invasive and high-definition solutions for EEG recording, brain stimulation, and ablation treatments for neurological disorders such as epilepsy and Parkinson’s disease. The company’s focus is on improving surg","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/neuroone-reports-record-revenue-boost-143036091.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/neuroone-reports-record-revenue-boost-143036091.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NMTC"],"gpt_icon":0},{"id":"2502152048","title":"NeuroOne Expects Higher Fiscal Q1 Revenue -- Shares Up","url":"https://stock-news.laohu8.com/highlight/detail?id=2502152048","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502152048?lang=en_us&edition=fundamental","pubTime":"2025-01-11 03:03","pubTimestamp":1736535784,"startTime":"0","endTime":"0","summary":"NeuroOne Medical Technologies  shares rose more than 9% in recent trading Friday after it said it expects fiscal Q1 revenue of $6.2 million, up from $1 million a year earlier.The company said the quarter ended Dec. 31, 2024, includes a one-time $3 million payment of collaboration revenue from the expanded distribution deal with Zimmer Biomet Holdings  for commercialization of NeuroOne's OneRF Ablation System.Price: 1.17, Change: +0.10, Percent Change: +9.35","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ZBH","NMTC"],"gpt_icon":0},{"id":"2502865038","title":"NeuroOne Expects $6.2M Q1 Fiscal 2025 Revenue, Including $3M One-Time Payment From Zimmer Biomet; Product Revenue Jumps 227% To $3.2M; FY25 Product Revenue Guidance Of $8M-$10M With 47%-51% Gross Margin","url":"https://stock-news.laohu8.com/highlight/detail?id=2502865038","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502865038?lang=en_us&edition=fundamental","pubTime":"2025-01-10 21:33","pubTimestamp":1736516036,"startTime":"0","endTime":"0","summary":"First Quarter Fiscal 2025 Revenue Includes a One-Time Upfront Payment of $3.0 Million in Collaboration Revenue from Zimmer Biomet and $3.2M in Product RevenueManagement to Host Virtual Investor Webinar Today at 11:00","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/01/42912284/neuroone-expects-6-2m-q1-fiscal-2025-revenue-including-3m-one-time-payment-from-zimmer-biomet-produ","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MMM","NMTC","ZBH"],"gpt_icon":0},{"id":"2502865496","title":"Neuroone Medical Technologies Corp:  for Full Year of Fiscal 2025, Co Is Reiterating Guidance Specific to Product Revenues","url":"https://stock-news.laohu8.com/highlight/detail?id=2502865496","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502865496?lang=en_us&edition=fundamental","pubTime":"2025-01-10 21:30","pubTimestamp":1736515801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250110:nTUA6YMBXQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","NMTC"],"gpt_icon":0},{"id":"2502651968","title":"Neuroone® Announces Preliminary Unaudited First Quarter Fiscal 2025 Revenue Increase to a Record $6.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2502651968","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502651968?lang=en_us&edition=fundamental","pubTime":"2025-01-10 21:30","pubTimestamp":1736515801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250110:nTUA6YMBXQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NMTC","BK4082"],"gpt_icon":0},{"id":"2502642698","title":"NeuroOne® Announces Preliminary Unaudited First Quarter Fiscal 2025 Revenue Increase to a Record $6.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2502642698","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502642698?lang=en_us&edition=fundamental","pubTime":"2025-01-10 21:30","pubTimestamp":1736515800,"startTime":"0","endTime":"0","summary":"First Quarter Fiscal 2025 Revenue Includes a One-Time Upfront Payment of $3.0 Million in Collaboration Revenue from Zimmer Biomet and $3.2M in Product Revenue. Management to Host Virtual Investor Webinar Today at 11:00 a.m. Eastern Time. Complete financial results for the quarter are expected to be announced in February 2025. The selected unaudited results in this press release are preliminary and subject to the completion of accounting and interim review procedures and are therefore subject to adjustment. This preliminary financial information is the responsibility of management and has been prepared in good faith on a consistent basis with prior periods. As a result, prospective investors should exercise caution in relying on this information and should not draw any inferences from this information regarding the Company’s financial information that is not provided. This preliminary financial inform","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/neuroone-announces-preliminary-unaudited-first-133000414.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NMTC"],"gpt_icon":0},{"id":"2501201412","title":"Apogee Enterprises Reports Fiscal 2025 Third Quarter Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2501201412","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501201412?lang=en_us&edition=fundamental","pubTime":"2025-01-07 19:30","pubTimestamp":1736249400,"startTime":"0","endTime":"0","summary":"Operating margin of 8.4%; and adjusted operating margin of 10.4%. Diluted EPS of $0.96 and adjusted diluted EPS of $1.19. Year-to-date cash flow from operations of $95 million. MINNEAPOLIS, January 07, 2025----Apogee Enterprises, Inc.  today reported its results for the third quarter of fiscal 2025. The Company reported the following selected financial results:. Ty R. Silberhorn, Chief Executive Officer stated, \"Our team remains focused on strengthening our operating foundation and positioning the company for long-term growth, despite continued pressure from soft demand in our end markets which is impacting results in the near term. During the quarter, we completed our acquisition of UW Solutions, expanding the capabilities and market opportunity in our LSO segment and creating a platform we expect to drive future growth.\". Selling, general and administrative  expenses as a percent of net sales increased 220 basis points to 17.7%, primarily due to acquisition-related expenses associate","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/apogee-enterprises-reports-fiscal-2025-113000564.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["DGNX","IE00BSNM7G36.USD","A","BK4082","BK4080","E","BK4106","SKBL","J","H","NMTC","S","BK4231","IE00B29SXL02.USD","O","DXST","APOG","LU0347712357.USD","BK4560","IE00B3T34201.USD","LU0130517989.USD","G","B","IE00BZ18W340.USD","LU0072461881.USD","LU1543694498.USD","F","LU0052756011.USD","LBRJ","BK4566","LU0648001328.SGD","R","MIMI","BK4567","K","LU2456880835.USD","LU0702159699.USD","LU0702159343.USD","LU2236285917.USD","IE00BMG7P694.USD","BK4212","IE00BMG7P926.USD","LU2417539215.USD","L","BLIV","HKPD","BK4121","D"],"gpt_icon":0},{"id":"2501167232","title":"NeuroOne Medical announces change to virtual investor webinar","url":"https://stock-news.laohu8.com/highlight/detail?id=2501167232","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501167232?lang=en_us&edition=fundamental","pubTime":"2025-01-06 21:46","pubTimestamp":1736171202,"startTime":"0","endTime":"0","summary":"NeuroOne Medical (NMTC) Technologies announced a change to its Virtual Investor Webinar date due to U.S. equity markets being closed for the Nation...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neuroone-medical-announces-change-to-virtual-investor-webinar?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neuroone-medical-announces-change-to-virtual-investor-webinar?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NMTC","BK4082"],"gpt_icon":0},{"id":"2501232384","title":"NeuroOne® Announces Change of Virtual Investor Webinar to Friday, January 10, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2501232384","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501232384?lang=en_us&edition=fundamental","pubTime":"2025-01-06 21:30","pubTimestamp":1736170200,"startTime":"0","endTime":"0","summary":"Company to Provide Overview of Business Model and Expected Revenue Acceleration in Fiscal Year 2025. EDEN PRAIRIE, Minn., Jan. 06, 2025  -- NeuroOne Medical Technologies Corporation  , a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announced today a change to its Virtual Investor Webinar date due to U.S. equity markets being closed for the National Day of Mourning for former U.S. President Jimmy Carter.Dave Rosa, Chief Executive Officer of NeuroOne, will provide an overview of the business model and discuss recent milestone achievements, including its recently expanded exclusive distribution agreement with Zimmer Biomet, one of the world’s largest medical device manufacturers. Following the Company’s recently announced product revenue growth of 77% to $3.5 million in fiscal year 2024, the Company is expecting product revenue to increase to between $8 and $10 million in fiscal year 2025, representi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/neuroone-announces-change-virtual-investor-133000772.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4082","NMTC"],"gpt_icon":0},{"id":"2500163371","title":"NeuroOne® Announces Virtual Investor Webinar on January 9, 2025 at 11:00 a.m. EST","url":"https://stock-news.laohu8.com/highlight/detail?id=2500163371","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500163371?lang=en_us&edition=fundamental","pubTime":"2025-01-03 21:30","pubTimestamp":1735911000,"startTime":"0","endTime":"0","summary":"Company to Provide Overview of Business Model and Expected Revenue Acceleration in Fiscal Year 2025. EDEN PRAIRIE, Minn., Jan. 03, 2025  -- NeuroOne Medical Technologies Corporation  , a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announced today that it will hold a virtual roadshow webinar to discuss its business operations and recent updates.Dave Rosa, Chief Executive Officer of NeuroOne, will provide an overview of the business model and discuss recent milestone achievements, including its recently expanded exclusive distribution agreement with Zimmer Biomet, one of the world’s largest medical device manufacturers. Following the Company’s recently announced product revenue growth of 77% to $3.5 million in fiscal year 2024, the Company is expecting product revenue to increase to between $8 and $10 million in fiscal year 2025, representing an increase of between 132% and 190%.The webcast will be","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/neuroone-announces-virtual-investor-webinar-133000229.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NMTC","BK4082"],"gpt_icon":0},{"id":"2492131259","title":"NeuroOne Medical Technologies Corp (NMTC) Q4 2024 Earnings Call Highlights: Strategic ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2492131259","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492131259?lang=en_us&edition=fundamental","pubTime":"2024-12-19 01:00","pubTimestamp":1734541229,"startTime":"0","endTime":"0","summary":"For the complete transcript of the earnings call, please refer to the full earnings call transcript.NeuroOne Medical Technologies Corp  successfully achieved 510 clearance from the FDA for their OneRF Ablation System, marking it as the first and only FDA-cleared system for both electrical activity reporting and nervous tissue ablation.The company secured a strategic partnership with Zimmer Biomet, providing a broad distribution network in the US and certain international geographies.NeuroOne received a $3 million upfront license payment from Zimmer Biomet, with potential for additional milestone payments, strengthening their financial position.The company projects significant revenue growth for fiscal year 2025, with expected revenue between $8 million and $10 million, representing a 132% to 190% increase over 2024.Cash and cash equivalents decreased significantly to $1.5 million as of September 30, 2024, from $5.3 million the previous year, indicating potential liquidity concerns.Work","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/3cZx7YUMyAr5LJS5MqIYQg--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/f90cc90b138c640893550fa4830f9628","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/3cZx7YUMyAr5LJS5MqIYQg--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/f90cc90b138c640893550fa4830f9628"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/neuroone-medical-technologies-corp-nmtc-170029389.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NMTC","ZBH"],"gpt_icon":0},{"id":"2492957952","title":"NeuroOne FY24 Product Revenue Of $3.45M Vs. $1.95M YoY, GAAP EPS Loss Of $0.46 Compared To $0.65 YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2492957952","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492957952?lang=en_us&edition=fundamental","pubTime":"2024-12-17 21:41","pubTimestamp":1734442865,"startTime":"0","endTime":"0","summary":"NeuroOne FY24 Product Revenue Of $3.45M Vs. $1.95M YoY, GAAP EPS Loss Of $0.46 Compared To $0.65 YoY","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/12/42529672/neuroone-fy24-product-revenue-of-3-45m-vs-1-95m-yoy-gaap-eps-loss-of-0-46-compared-to-0-65-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"NeuroOne FY24 Product Revenue Of $3.45M Vs. $1.95M YoY, GAAP EPS Loss Of $0.46 Compared To $0.65 YoY","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NMTC"],"gpt_icon":0},{"id":"2492952254","title":"Neuroone® Product Revenue Increases 77% to $3.5 Million in Fiscal 2024: Expects Product Revenue to Increase at Least 132% to at Least $8 Million in Fiscal 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2492952254","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492952254?lang=en_us&edition=fundamental","pubTime":"2024-12-17 21:30","pubTimestamp":1734442201,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241217:nTUAC3KNXG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NMTC","BK4082"],"gpt_icon":0},{"id":"2492952258","title":"Neuroone Medical Technologies Q4 Net Income USD -3.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2492952258","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492952258?lang=en_us&edition=fundamental","pubTime":"2024-12-17 21:30","pubTimestamp":1734442200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241217:nPLX183C8B:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","NMTC"],"gpt_icon":0},{"id":"2492952238","title":"Neuroone Medical Technologies Q4 Operating Expenses USD 3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2492952238","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492952238?lang=en_us&edition=fundamental","pubTime":"2024-12-17 21:30","pubTimestamp":1734442200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241217:nPLX183C8B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NMTC","BK4082"],"gpt_icon":0},{"id":"2492952709","title":"NeuroOne® Product Revenue Increases 77% to $3.5 Million in Fiscal 2024: Expects Product Revenue to Increase at Least 132% to at Least $8 Million in Fiscal 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2492952709","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492952709?lang=en_us&edition=fundamental","pubTime":"2024-12-17 21:30","pubTimestamp":1734442200,"startTime":"0","endTime":"0","summary":"Company’s Exclusive Distribution Agreement with Zimmer Biomet included $3.0 Million Upfront Payment: Expected to Drive Revenue and Expand Margins Significantly EDEN PRAIRIE, Minn., Dec.  17, 2024  (GL","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/17/2998268/0/en/NeuroOne-Product-Revenue-Increases-77-to-3-5-Million-in-Fiscal-2024-Expects-Product-Revenue-to-Increase-at-Least-132-to-at-Least-8-Million-in-Fiscal-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4143","SCS","NMTC"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":59,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NMTC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-13","symbol":"NMTC","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"pre","actualEps":-0.07},{"market":"US","date":"2025-02-12","symbol":"NMTC","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1739336400000,"reportTimeType":"pre","actualEps":0.06},{"market":"US","date":"2025-01-10","symbol":"NMTC","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1736485200000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2024-12-17","symbol":"NMTC","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1734411600000,"reportTimeType":"pre","actualEps":-0.11},{"market":"US","date":"2024-08-14","symbol":"NMTC","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723608000000,"reportTimeType":"post","actualEps":-0.1}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NMTC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NMTC\",market:\"US\",delay:false,,,undefined,":{"strongBuy":1,"buy":0,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":1,"analysts":1,"updateTime":1746504000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NMTC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NMTC","date":"2025-06-11","current":-4.383972,"percent":0.102941,"low":-5.152424,"twenty":-3.722076,"median":-2.363342,"eighty":-2.011247,"high":-1.439522,"avg":-2.722313,"sd":0.938034,"marketCap":28949143},"quantilePoints":[{"date":"2024-01-05","current":-3.152078,"twenty":-3.152078,"median":-3.152078,"eighty":-3.152078,"marketCap":37382041},{"date":"2024-01-12","current":-2.966641,"twenty":-3.158726,"median":-3.134059,"eighty":-3.111667,"marketCap":35182851},{"date":"2024-01-19","current":-2.88127,"twenty":-3.153408,"median":-3.039154,"eighty":-2.915418,"marketCap":34170395},{"date":"2024-01-26","current":-2.689185,"twenty":-3.123248,"median":-2.945298,"eighty":-2.872733,"marketCap":31892369},{"date":"2024-02-02","current":-3.038108,"twenty":-3.112542,"median":-2.923955,"eighty":-2.729733,"marketCap":36030419},{"date":"2024-02-09","current":-2.753969,"twenty":-3.070305,"median":-2.923955,"eighty":-2.729733,"marketCap":32660667},{"date":"2024-02-16","current":-2.021098,"twenty":-3.070305,"median":-2.902613,"eighty":-2.712471,"marketCap":27227472},{"date":"2024-02-23","current":-2.117341,"twenty":-3.046851,"median":-2.859927,"eighty":-2.587856,"marketCap":28524018},{"date":"2024-03-01","current":-2.329075,"twenty":-3.024994,"median":-2.753969,"eighty":-2.198185,"marketCap":31376420},{"date":"2024-03-08","current":-2.406069,"twenty":-2.999291,"median":-2.726527,"eighty":-2.225133,"marketCap":32413657},{"date":"2024-03-15","current":-2.059595,"twenty":-2.985273,"median":-2.710255,"eighty":-2.186636,"marketCap":27746090},{"date":"2024-03-22","current":-2.13659,"twenty":-2.973371,"median":-2.639564,"eighty":-2.13659,"marketCap":28783327},{"date":"2024-03-28","current":-2.319451,"twenty":-2.958104,"median":-2.489984,"eighty":-2.144289,"marketCap":31246765},{"date":"2024-04-05","current":-2.367572,"twenty":-2.936761,"median":-2.388746,"eighty":-2.163538,"marketCap":31895038},{"date":"2024-04-12","current":-2.329075,"twenty":-2.923955,"median":-2.386821,"eighty":-2.182786,"marketCap":31376420},{"date":"2024-04-19","current":-2.194335,"twenty":-2.906881,"median":-2.367572,"eighty":-2.182786,"marketCap":29561255},{"date":"2024-04-26","current":-2.13659,"twenty":-2.88127,"median":-2.348324,"eighty":-2.182786,"marketCap":28783327},{"date":"2024-05-03","current":-2.329075,"twenty":-2.864196,"median":-2.329075,"eighty":-2.175087,"marketCap":31376420},{"date":"2024-05-10","current":-2.232832,"twenty":-2.813481,"median":-2.324263,"eighty":-2.175087,"marketCap":30079874},{"date":"2024-05-17","current":-2.126501,"twenty":-2.767083,"median":-2.308772,"eighty":-2.155838,"marketCap":27227472},{"date":"2024-05-24","current":-2.207511,"twenty":-2.745226,"median":-2.271329,"eighty":-2.155838,"marketCap":28264709},{"date":"2024-05-31","current":-1.914053,"twenty":-2.732064,"median":-2.261705,"eighty":-2.146753,"marketCap":24507318},{"date":"2024-06-07","current":-1.846154,"twenty":-2.729733,"median":-2.252081,"eighty":-2.13659,"marketCap":23637945},{"date":"2024-06-14","current":-2.069476,"twenty":-2.721183,"median":-2.249194,"eighty":-2.126501,"marketCap":26497329},{"date":"2024-06-21","current":-1.804839,"twenty":-2.714657,"median":-2.232832,"eighty":-2.100768,"marketCap":23108945},{"date":"2024-06-28","current":-1.615657,"twenty":-2.712471,"median":-2.232832,"eighty":-2.078218,"marketCap":20686682},{"date":"2024-07-05","current":-1.848329,"twenty":-2.710255,"median":-2.232832,"eighty":-2.069476,"marketCap":23665787},{"date":"2024-07-12","current":-2.022507,"twenty":-2.689185,"median":-2.213584,"eighty":-2.039685,"marketCap":25895940},{"date":"2024-07-15","current":-2.065779,"twenty":-2.682608,"median":-2.213584,"eighty":-2.039817,"marketCap":26449997},{"date":"2024-08-02","current":-1.563469,"twenty":-2.676031,"median":-2.213584,"eighty":-2.030552,"marketCap":20018472},{"date":"2024-08-09","current":-1.611525,"twenty":-2.642911,"median":-2.207511,"eighty":-2.008766,"marketCap":20633782},{"date":"2024-08-16","current":-1.857244,"twenty":-2.587856,"median":-2.194335,"eighty":-1.98032,"marketCap":22477552},{"date":"2024-08-23","current":-2.011247,"twenty":-2.499067,"median":-2.187258,"eighty":-1.978947,"marketCap":24341385},{"date":"2024-08-30","current":-2.060127,"twenty":-2.444567,"median":-2.175087,"eighty":-1.978947,"marketCap":24932973},{"date":"2024-09-06","current":-1.960329,"twenty":-2.436867,"median":-2.155838,"eighty":-1.978799,"marketCap":23725147},{"date":"2024-09-13","current":-2.137268,"twenty":-2.402604,"median":-2.155838,"eighty":-1.978799,"marketCap":25866573},{"date":"2024-09-20","current":-2.380399,"twenty":-2.388361,"median":-2.155838,"eighty":-1.978873,"marketCap":28809107},{"date":"2024-09-27","current":-2.494964,"twenty":-2.436867,"median":-2.155838,"eighty":-1.979855,"marketCap":30195642},{"date":"2024-10-04","current":-2.36767,"twenty":-2.489872,"median":-2.175087,"eighty":-1.985012,"marketCap":28655048},{"date":"2024-10-11","current":-2.316752,"twenty":-2.515331,"median":-2.187258,"eighty":-1.994698,"marketCap":28038810},{"date":"2024-10-18","current":-2.36767,"twenty":-2.489872,"median":-2.194335,"eighty":-1.994929,"marketCap":28655048},{"date":"2024-10-25","current":-2.545627,"twenty":-2.489872,"median":-2.207511,"eighty":-1.996274,"marketCap":30808798},{"date":"2024-10-31","current":-2.507693,"twenty":-2.507693,"median":-2.213584,"eighty":-2.000544,"marketCap":30349701},{"date":"2024-11-08","current":-2.304023,"twenty":-2.494964,"median":-2.218396,"eighty":-2.001063,"marketCap":27884751},{"date":"2024-11-15","current":-1.988334,"twenty":-2.469505,"median":-2.223208,"eighty":-2.001063,"marketCap":24064078},{"date":"2024-11-22","current":-1.781608,"twenty":-2.469505,"median":-2.213584,"eighty":-1.994658,"marketCap":21562153},{"date":"2024-11-29","current":-1.586339,"twenty":-2.449555,"median":-2.210547,"eighty":-1.979094,"marketCap":19198882},{"date":"2024-12-06","current":-1.527529,"twenty":-2.444567,"median":-2.194335,"eighty":-1.954281,"marketCap":18487128},{"date":"2024-12-13","current":-1.94429,"twenty":-2.440892,"median":-2.194335,"eighty":-1.928958,"marketCap":23531032},{"date":"2024-12-20","current":-1.897865,"twenty":-2.422863,"median":-2.186912,"eighty":-1.922356,"marketCap":23378107},{"date":"2024-12-27","current":-2.155754,"twenty":-2.418434,"median":-2.175087,"eighty":-1.92028,"marketCap":26554815},{"date":"2025-01-03","current":-2.065117,"twenty":-2.413427,"median":-2.155838,"eighty":-1.925043,"marketCap":25438341},{"date":"2025-01-10","current":-2.704082,"twenty":-2.435695,"median":-2.175087,"eighty":-1.92625,"marketCap":33309176},{"date":"2025-01-17","current":-2.604181,"twenty":-2.469505,"median":-2.187085,"eighty":-1.927409,"marketCap":32078587},{"date":"2025-01-24","current":-2.804233,"twenty":-2.520423,"median":-2.194335,"eighty":-1.927409,"marketCap":34542849},{"date":"2025-01-31","current":-2.879346,"twenty":-2.5354,"median":-2.194335,"eighty":-1.93009,"marketCap":35468104},{"date":"2025-02-07","current":-2.485752,"twenty":-2.545627,"median":-2.210547,"eighty":-1.935379,"marketCap":30619768},{"date":"2025-02-14","current":-4.894803,"twenty":-2.57134,"median":-2.213584,"eighty":-1.94429,"marketCap":35183297},{"date":"2025-02-21","current":-4.80893,"twenty":-2.603981,"median":-2.223208,"eighty":-1.957121,"marketCap":34566047},{"date":"2025-02-28","current":-4.76771,"twenty":-2.660149,"median":-2.232832,"eighty":-1.960736,"marketCap":34269766},{"date":"2025-03-07","current":-4.379561,"twenty":-2.704082,"median":-2.232832,"eighty":-1.97462,"marketCap":31479792},{"date":"2025-03-14","current":-4.379561,"twenty":-2.72277,"median":-2.250637,"eighty":-1.978652,"marketCap":31479792},{"date":"2025-03-21","current":-4.293687,"twenty":-2.758113,"median":-2.252081,"eighty":-1.978799,"marketCap":30862542},{"date":"2025-03-28","current":-3.872906,"twenty":-2.809841,"median":-2.265835,"eighty":-1.979094,"marketCap":27838012},{"date":"2025-04-04","current":-3.692571,"twenty":-2.879346,"median":-2.271329,"eighty":-1.981914,"marketCap":26541786},{"date":"2025-04-11","current":-2.836056,"twenty":-2.879346,"median":-2.271329,"eighty":-1.981914,"marketCap":20385253},{"date":"2025-04-17","current":-3.722076,"twenty":-2.88127,"median":-2.290936,"eighty":-1.986041,"marketCap":26753867},{"date":"2025-04-25","current":-3.978521,"twenty":-2.932492,"median":-2.304023,"eighty":-1.992128,"marketCap":28597164},{"date":"2025-05-02","current":-4.074111,"twenty":-2.989597,"median":-2.313162,"eighty":-1.994779,"marketCap":29284255},{"date":"2025-05-09","current":-4.022031,"twenty":-3.032987,"median":-2.319451,"eighty":-1.995068,"marketCap":28909909},{"date":"2025-05-16","current":-4.707405,"twenty":-3.103727,"median":-2.329075,"eighty":-1.998409,"marketCap":31084905},{"date":"2025-05-23","current":-4.420369,"twenty":-3.162936,"median":-2.332028,"eighty":-2.000855,"marketCap":29189484},{"date":"2025-05-30","current":-4.580392,"twenty":-3.547773,"median":-2.342211,"eighty":-2.002081,"marketCap":30246181},{"date":"2025-06-06","current":-4.443572,"twenty":-3.692571,"median":-2.348324,"eighty":-2.006664,"marketCap":29342704},{"date":"2025-06-11","current":-4.383972,"twenty":-3.722076,"median":-2.363342,"eighty":-2.011247,"marketCap":28949143}],"updateTime":1749763962107}}}